Author

D. Meseure

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Nicolas· 4 shared A. Vincent-Salomon· 3 shared A. Brisson· 1 shared A. Herbette· 1 shared A. Latouche· 1 shared A. Simon· 1 shared B. Buttard· 1 shared B. Mboup· 1 shared

Activity by Year

2021-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

A. Nicolas

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Low centrosome numbers correlate with higher aggressivity in ovarian cancer

J.-P. Morretton, A. Simon, A. Herbette, J. Barbazan, C. Perez-Gonzalez, C. Cosson, B. Mboup, A. Latouche, T. Popova, Y. Kieffer, P. Gestraud, G. Bataillon, V. Becette, D. Meseure, A. Nicolas, , R. Basto

The paper analyzes centrosome numbers in ovarian cancers and finds that low centrosome numbers correlate with poor patient survival and mesenchymal subgroup enrichment.

bioRxiv · Jan 4, 2022 · PreprintCancer Biology

Cancer/Testis genes are predictive of breast tumor subtypes

M. Laisne, S. Benlarama, A. Nicolas, L. Djerroudi, N. Gupta, D. Daher, L. Ferry, O. Kirsh, C. Philippe, Y. Okada, G. Cristofari, D. Meseure, A. Vincent-Salomon, C. Ginestier, P.-A. Defossez

The paper identifies HORMAD1 and CT83 as Cancer/Testis genes predictive of basal-like breast tumors and shows their epigenetic regulation and prognostic significance.

bioRxiv · Oct 27, 2021 · PreprintCancer Biology

PRMT1 regulates EGFR and Wnt signaling pathways and is a promising target for combinatorial treatment of breast cancer

S. Suresh, S. Huard, A. Brisson, F. Nemati, C. Poulard, M. Ye, E. Martel, C. Reyes, D. C. Silvestre, D. Meseure, A. Nicolas, D. Gentien, M. Le Romancer, D. Decaudin, S. Roman-Roman, T. Dubois

This study identifies PRMT1 as a key regulator of EGFR and Wnt signaling in breast cancer and shows that targeting it with inhibitors can enhance chemotherapy and EGFR inhibitor efficacy in TNBC.

bioRxiv · Oct 22, 2021Cancer Biology

Tissue-resident FOLR2+ macrophages associate with tumor-infiltrating CD8+ T cells and with increased survival of breast cancer patients.

R. N. Ramos, Y. Missolo-Koussou, Y. Gerber-Ferder, C. Bromley, M. Bugatti, N. G. Nunez, J. Boari Tosello, W. Richer, J. Denizeau, C. Sedlik, P. Caudana, F. Kotsias, L. L. Niborski, S. Viel, M. Bohec, , J. Helft

The paper identifies FOLR2+ macrophages in breast cancer that correlate with improved patient survival and co-localize with CD8+ T cells across multiple cancers.

bioRxiv · Apr 12, 2021 · PreprintImmunology